ArticleKidney medicine2026
Kidney Transplant Complicated by Severe Parathyroid Hormone-Independent Hypercalcemia From Tumoral Calcinosis.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumoral calcinosis (TC) is a rare complication of progressive kidney failure, characterized by massive depositions of calcium and phosphate into the periarticular soft tissue. Although generally associated with hyperparathyroidism and an elevated calcium-phosphorus product, there are few curative treatments for this condition. Although kidney transplantation typically leads to complete resolution of TC, the early posttransplant course may paradoxically mobilize soft tissue calcium into the general circulation, causing severe hypercalcemia and renal allograft injury. We report a rare case of acute allograft injury from severe hypercalcemia in a kidney transplant recipient, with worsening of her preexisting TC. The hypercalcemia was resistant to standard and off-label therapies, including saline, loop diuresis, calcimimetics, and bisphosphonates. Eventually, this was resolved with the initiation of temporary hemodialysis and saline infusion. This patient's severe pretransplant hyperparathyroidism, use of calcium-containing phosphate binders with activated vitamin D analogs, and prolonged dialysis dependence contributed to her unique clinical course. This case emphasizes the importance of individualized bone-mineral metabolism optimization in high-risk patients considered for kidney transplantation to prevent dangerous mineral shifts and preserve future allograft function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.